Ingersoll Rand vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Ingersoll Rand trades at $78.16 (market cap $29.97B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Ingersoll Rand is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Ingersoll Rand for 7 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| IR | RPRX | |
|---|---|---|
Market Cap | $29.97B | $25.27B |
Volume | 4,688,805 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $98.76 | $63.96 |
52-Week Low | $68.54 | $35.44 |
Typical Hold Time | 7 Days | 0 Days |
Enterprise Value | $33.63B | $32.50B |
Dividend Yield | 0.1% | 1.66% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →